The medical devices industry continues to be a hotbed of innovation, with activity driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies such as machine learning, augmented reality, 5G and digitalisation. In the last three years alone, there have been over 450,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Innovation in Medical Devices: Bio-active prosthesis coating.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
150+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 550,000 patents, there are 150+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, neurostimulation therapy, smart physiotherapy devices, and real-time IR thermographic imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Precision radiotherapy, electric atomisers, and bio-active prosthesis coating are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are bioresorbable stent coating and cryogenic tissue treatment, which are now well established in the industry.
Innovation S-curve for the medical devices industry
Bio-active prosthesis coating is a key innovation area in the medical devices industry
Bio-active prosthesis coatings are coatings with the capacity to chemically bind directly with living tissues, such as soft tissue and bone. Due to their distinctive capacity to build a link between the bone and surrounding tissues, these bioactive prosthesis coatings are mostly used as coating materials in orthopedic and dental implants. The coating is utilized to promote the growth of bone tissue into and around the prosthesis surface.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of bio-active prosthesis coating.
Key players in bio-active prosthesis coating – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to bio-active prosthesis coating
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|AbbVie||55||Unlock company profile|
|Medtronic||47||Unlock company profile|
|Merz PharmaaA||29||Unlock company profile|
|Spotlight Technology Partners||26||Unlock company profile|
|Croma-Pharma||25||Unlock company profile|
|Mati Therapeutics||22||Unlock company profile|
|Orthopaedic Innovation Centre||21||Unlock company profile|
|Teijin||20||Unlock company profile|
|Becton Dickinson and Co||15||Unlock company profile|
|Kona Gold Beverage||14||Unlock company profile|
|Johnson & Johnson||14||Unlock company profile|
|P&R||13||Unlock company profile|
|Hkl Medical||13||Unlock company profile|
|Ministry of Trade and Industry, Singapore||9||Unlock company profile|
|Klox Technologies||9||Unlock company profile|
|QLT Plug Delivery||9||Unlock company profile|
|Tyco Healthcare Group||9||Unlock company profile|
|Fujifilm Holdings||7||Unlock company profile|
|Integra LifeSciences Holdings||7||Unlock company profile|
|Abbott Laboratories||7||Unlock company profile|
|Bezwada Biomedical||7||Unlock company profile|
|Halscion||7||Unlock company profile|
|Singapore Health Services||6||Unlock company profile|
|Omeros||5||Unlock company profile|
|ODIN Biotech Partners||5||Unlock company profile|
|Reflex Medical||5||Unlock company profile|
Source: GlobalData Patent Analytics
AbbVie is one of the leading patent filers in the field of bio-active prosthesis coating. Some other key patent filers in the field include Medtronic, Merz Pharma, Spotlight Technology Partners and Croma-Pharma.
In terms of application diversity, ODIN Biotech Partners leads the pack, followed by Mati Therapeutics and QLT Plug Delivery. By means of geographic reach, Merz Pharma held the top position, followed by P&R and Croma-Pharma in second and third spots, respectively.
The failure of conventional surface modification techniques to produce a friendly surface covering for implants is largely due to corrosion. Therefore, bioactive prosthetic coating has a bright future in biomedical applications. Long term, sustainable coatings research efforts should be devoted to further enhancing and managing their physiochemical characteristics. Even better, because they allow for workability in composition and characteristics, composite coatings on implants may be tailored to the demands of the host.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.